Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2018

Open Access 01-12-2018 | Research

Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease

Authors: Manuel Monroy, Miguel A. Ruiz, Javier Rejas, Javier Soto

Published in: Health and Quality of Life Outcomes | Issue 1/2018

Login to get access

Abstract

Background

The short, self-administered Gastroesophageal Reflux Disease (GERD) Symptom Frequency Questionnaire (GSFQ) is a specific Quality of Life (QoL) instrument which measures the impact of GERD symptoms on QoL. This study aims to map the specific scores in GSFQ into two generic instruments: SF-6D and EQ-5D-3 L, in order to obtain utility estimates derived from the GERD condition.

Method

A national representative sample of GERD patients was selected, stratified by gender, age (< 45, ≥45 years) and GERD severity (0-I, II-IV Savary-Miller score) for validation purposes. Age, gender, BMI, GERD diagnose, GERD severity, associated comorbidities and risk factors were recorded. GSFQ, SF-6D, EQ-5D-3 L, and the HRQoL Visual Analogue Scale (VAS) were answered by patients. Several mapping methods were estimated, regression using dummy variables, and linear, quadratic and cubic regression using optimal factor scores. The use of a GERD aggregated summary severity derived from the GSFQ was dimed the best predictor. Overall Mean Absolute Error (MAE), overall Mean Absolute Percentage Error (MAPE) were used as goodness-of-fit (GOF) indexes to compare models.

Results

A total of 3405 patients were recruited by 490 clinicians. Mean age was 49 (±14.4) years and 49.8% were women. Reported comorbidities were clustered in 6 antecedents and 15 concomitant pathologies. Aggregation of levels for the frequency of symptoms items was found more suitable for estimation. Regression weights were found to follow a monotonous progressive pattern. Overall MAE ranged from 0.092 to 0.094 for SF-6D utility prediction and from 0.008 to 0.08 for EQ-5D-3 L, while MAPE values ranged from 27.9 to 29% for SF-6D and from 36.8 to 38.4% for EQ-5D-3 L. Cubic regression GOF demonstrated a better fit.

Conclusions

It is possible to translate specific GSFQ scores assessing GERD condition into generic SF-6D and EQ-5D-3 L utility values. Although regression using dummy variables is a suitable mapping procedure, other alternative mapping methods convey better fit, in particular cubic regression.
Literature
1.
go back to reference Winkelstein A. Peptic esophagitis: a new clinical entity. JAMA. 1935;104:906–9.CrossRef Winkelstein A. Peptic esophagitis: a new clinical entity. JAMA. 1935;104:906–9.CrossRef
2.
go back to reference Ing AJ, Ngy MC, Breslin ABX. The pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Rtspir Crit Care Med. 1994;149:160–7.CrossRef Ing AJ, Ngy MC, Breslin ABX. The pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Rtspir Crit Care Med. 1994;149:160–7.CrossRef
3.
go back to reference Marzo M, Alonso P, Bonfill X, Fernández M, Fernández J, Martínez G, Mearín F, Mascort JJ, Piqué JM, Ponce J, Sáez M. Guía de práctica clínica sobre el manejo del paciente con enfermedad por reflujo gastroesofágico (ERGE). Gastroenterol Hepatol. 2002;25:85–110.CrossRefPubMed Marzo M, Alonso P, Bonfill X, Fernández M, Fernández J, Martínez G, Mearín F, Mascort JJ, Piqué JM, Ponce J, Sáez M. Guía de práctica clínica sobre el manejo del paciente con enfermedad por reflujo gastroesofágico (ERGE). Gastroenterol Hepatol. 2002;25:85–110.CrossRefPubMed
4.
go back to reference Stranghellini V. Three month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the domestic international Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl. 1999:20–8. Stranghellini V. Three month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the domestic international Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl. 1999:20–8.
5.
go back to reference Dent J, Brun J, Fendrick AM, Fennerty MB, Jansens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management. The Genval Workshop Report. Gut. 1999;44(Supl 2):S1–S16.CrossRefPubMedCentral Dent J, Brun J, Fendrick AM, Fennerty MB, Jansens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management. The Genval Workshop Report. Gut. 1999;44(Supl 2):S1–S16.CrossRefPubMedCentral
6.
go back to reference Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–9.CrossRefPubMed Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–9.CrossRefPubMed
7.
go back to reference Arín A, Iglesias MR. Enfermedad por reflujo gastroesofágico. Anales del Sistema Sanitario de Navarra (2003). Arín A, Iglesias MR. Enfermedad por reflujo gastroesofágico. Anales del Sistema Sanitario de Navarra (2003).
8.
go back to reference Hardin SM, Rchter JE, Guzzo MR, Schan CA, Alexander RW, Bradley LA. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med. 1996;100:395–405.CrossRef Hardin SM, Rchter JE, Guzzo MR, Schan CA, Alexander RW, Bradley LA. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med. 1996;100:395–405.CrossRef
10.
go back to reference Pare P, Meyer F, Armstrong D, Pyzyk M, Pericak D, Goeree R. Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. Can J Gastroenterol. 2003;17:307–12.CrossRefPubMed Pare P, Meyer F, Armstrong D, Pyzyk M, Pericak D, Goeree R. Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. Can J Gastroenterol. 2003;17:307–12.CrossRefPubMed
11.
go back to reference Alonso J. La medida de la calidad de vida relacionada con la salud en la investigación y en la práctica clínica Unidad de Investigación en Servicios Sanitarios. Institut Municipal d’ investigación Mèdica (IMIM) 1999. Alonso J. La medida de la calidad de vida relacionada con la salud en la investigación y en la práctica clínica Unidad de Investigación en Servicios Sanitarios. Institut Municipal d’ investigación Mèdica (IMIM) 1999.
12.
go back to reference Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716–21.CrossRefPubMed Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716–21.CrossRefPubMed
13.
go back to reference Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215–25.CrossRefPubMed Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215–25.CrossRefPubMed
14.
go back to reference Brazier J, Tsuchiya A. Preference-based condition-specific measures of health: what happens to cross programme comparability? Health Econ. 2010;19(2):125–9.CrossRefPubMed Brazier J, Tsuchiya A. Preference-based condition-specific measures of health: what happens to cross programme comparability? Health Econ. 2010;19(2):125–9.CrossRefPubMed
15.
go back to reference Kearns B, Ara R, Wailoo A, et al. Good practice guidelines for the use of statistical regression models in economic evaluations. Pharmacoeconomics. 2013;31:643–52.CrossRefPubMed Kearns B, Ara R, Wailoo A, et al. Good practice guidelines for the use of statistical regression models in economic evaluations. Pharmacoeconomics. 2013;31:643–52.CrossRefPubMed
16.
go back to reference Wailoo AJ, Hernandez-Alava M, Manca A, et al. Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report. Value Health. 2017;20:18–27.CrossRefPubMed Wailoo AJ, Hernandez-Alava M, Manca A, et al. Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report. Value Health. 2017;20:18–27.CrossRefPubMed
17.
go back to reference Ruiz MA, Suárez JM, Pardo A, García-Vargas M, Pascual V. Cultural adaptation to Spanish and validation of the Gastrointestinal Short Form Questionnaire. Gastroenterol Hepatol. 2009;32(1):9–21.CrossRef Ruiz MA, Suárez JM, Pardo A, García-Vargas M, Pascual V. Cultural adaptation to Spanish and validation of the Gastrointestinal Short Form Questionnaire. Gastroenterol Hepatol. 2009;32(1):9–21.CrossRef
18.
go back to reference EuroQoL Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;6(3):199–208. EuroQoL Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;6(3):199–208.
19.
go back to reference Badia X, et al. La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc). 1999;112(Supl. 1):79–86. Badia X, et al. La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc). 1999;112(Supl. 1):79–86.
20.
go back to reference Dolan P, Sutton M. Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values. Soc Sci Med. 1997;44:1519–30.CrossRefPubMed Dolan P, Sutton M. Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values. Soc Sci Med. 1997;44:1519–30.CrossRefPubMed
21.
go back to reference Szende A, Oppe M, Devlin N (Eds.). EQ-5D Value Sets: Inventory, Comparative Review and User Guide. Springer; 2007. Szende A, Oppe M, Devlin N (Eds.). EQ-5D Value Sets: Inventory, Comparative Review and User Guide. Springer; 2007.
22.
go back to reference Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.CrossRefPubMed Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.CrossRefPubMed
23.
go back to reference Abellan Perpinan JM. Utilidades SF-6D para España. Guía de uso 2012/8. Sevilla: Catedra de Economía de la Salud. Universidad Pablo de Olavide. Consejería de Salud de la Junta de Andalucía; 2012. Abellan Perpinan JM. Utilidades SF-6D para España. Guía de uso 2012/8. Sevilla: Catedra de Economía de la Salud. Universidad Pablo de Olavide. Consejería de Salud de la Junta de Andalucía; 2012.
24.
go back to reference Vilagut G. El cuestionario de salud SF36 español: una década de experiencia y nuevos desarrollos. Unidad de Investigación en Servicios Sanitarios. Institut Municipal d’Investigació Mèdica (IMIM-IMAS). Barcelona. España. Gac Sanit. 2005;19(2):135–50.CrossRefPubMed Vilagut G. El cuestionario de salud SF36 español: una década de experiencia y nuevos desarrollos. Unidad de Investigación en Servicios Sanitarios. Institut Municipal d’Investigació Mèdica (IMIM-IMAS). Barcelona. España. Gac Sanit. 2005;19(2):135–50.CrossRefPubMed
25.
go back to reference Masters GN. A Rasch model for partial credit scoring. Psychometrika. 1982;47(2):149–74.CrossRef Masters GN. A Rasch model for partial credit scoring. Psychometrika. 1982;47(2):149–74.CrossRef
26.
go back to reference Teruel C, Faro V, Muriel A, Mañas N. Sensitivity and specificity of the Gastrointestinal Short Form Questionnaire in diagnosis of gastroesophageal reflux disease. Rev Esp Enferm Dig. 2016;108(4):174–80. Teruel C, Faro V, Muriel A, Mañas N. Sensitivity and specificity of the Gastrointestinal Short Form Questionnaire in diagnosis of gastroesophageal reflux disease. Rev Esp Enferm Dig. 2016;108(4):174–80.
27.
go back to reference Ratcliffe J, Brazier J, Tsuchiya A, Symonds T, Brown M. Using DCE and ranking data to estimate cardinal values for health states for deriving a preference-based single index from the sexual quality of life questionnaire. Health Econ. 2009;18(11):1261–76.CrossRefPubMed Ratcliffe J, Brazier J, Tsuchiya A, Symonds T, Brown M. Using DCE and ranking data to estimate cardinal values for health states for deriving a preference-based single index from the sexual quality of life questionnaire. Health Econ. 2009;18(11):1261–76.CrossRefPubMed
28.
go back to reference Coyne K, Revicki D, Hunt T, Corey R, Stewart W. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q. Qual Life Res. 2002;11(6):563–74.CrossRefPubMed Coyne K, Revicki D, Hunt T, Corey R, Stewart W. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q. Qual Life Res. 2002;11(6):563–74.CrossRefPubMed
Metadata
Title
Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease
Authors
Manuel Monroy
Miguel A. Ruiz
Javier Rejas
Javier Soto
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2018
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-018-1003-y

Other articles of this Issue 1/2018

Health and Quality of Life Outcomes 1/2018 Go to the issue